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Abstract
Background: In February 2015, the World Health Organization (WHO) released “Strategies toward ending
preventable maternal mortality (EPMM)” (EPMM Strategies), a direction-setting report outlining global targets and
strategies for reducing maternal mortality in the Sustainable Development Goal (SDG) period. In May 2015, the
EPMM Working Group outlined a plan to develop a comprehensive monitoring framework to track progress toward
the achievement of these targets and priorities. This monitoring framework was developed in two phases. Phase I,
which focused on identifying indicators related to the proximal causes of maternal mortality, was completed in
October 2015. This paper describes the process and results of Phase II, which was completed in November 2016
and aimed to build consensus on a set of indicators that capture information on the social, political, and economic
determinants of maternal health and mortality.
Findings: A total of 150 experts from more than 78 organizations worldwide participated in this second phase of
the process to develop a comprehensive monitoring framework for EPMM. The experts considered a total of 118
indicators grouped into the 11 key themes outlined in the EPMM report, ultimately reaching consensus on a set of
25 indicators, five equity stratifiers, and one transparency stratifier.
Conclusion: The indicators identified in Phase II will be used along with the Phase I indicators to monitor progress
towards ending preventable maternal deaths. Together, they provide a means for monitoring not only the essential
clinical interventions needed to save lives but also the equally important political, social, economic and health
system determinants of maternal health and survival. These distal factors are essential to creating the enabling
environment and high-performing health systems needed to ensure high-quality clinical care at the point of service
for every woman, her fetus and newborn. They complement and support other monitoring efforts, in particular the
“Survive, Thrive, and Transform” agenda laid out by the Global Strategy for Women’s, Children’s and Adolescents’
Health (2016-2030) and the SDG3 global target on maternal mortality.
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Background
Global maternal mortality remains unacceptably high,
with an estimated 303,000 women dying each year as a
result of pregnancy and childbirth-related complications
[1]. Although maternal deaths worldwide declined by
44% between 1990 and 2015, this achievement fell far
short of the 75% reduction targeted by Millennium Devel-
opment Goal 5a [1, 2]. As of 2015, 25 countries still had a
maternal mortality ratio (MMR) of 420 per 100,000 live
births or greater [1, 2]. Furthermore, the staggering 80-
fold difference in the estimated lifetime risk of maternal
mortality in low-income countries, as compared to high-
income countries, points to the persistence of profound
inequality that must be addressed.
The reasons for lack of progress are complex and
multifactorial. A recent series on maternal health points
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out increasing diversification in the causes of maternal
mortality and morbidity that health systems are ill
equipped to address. Disparities in access to care espe-
cially for vulnerable populations, poor quality of available
care, grave deficiencies in health system infrastructure and
workforce, and the impact of economic, political, socio-
demographic and environmental factors all contribute sig-
nificantly to the risk of poor maternal health outcomes
and impede progress toward reduction of mortality and
morbidity [3–8].
To address the lack of steady progress across all coun-
tries and reassert the importance of the unfinished agenda
of reducing maternal mortality in the Sustainable Devel-
opment Goal (SDG) era, the World Health Organization
(WHO) released a direction setting report entitled “Strat-
egies toward ending preventable maternal mortality
(EPMM)” (EPMM Strategies) in February 2015 [9]. The
report, developed through extensive consultations led by
the EPMM Working Group1, outlines targets and strat-
egies for reducing preventable maternal deaths worldwide.
The targets are both national and global (Table 1). The
global target was adopted by the SDG framework.
The strategies outlined in the report are exemplified
by 11 key themes that are grounded in a human rights-
based approach to health and focus heavily on the prin-
ciples of equity and non-discrimination, transparency,
participation, and accountability to ensure that repro-
ductive, maternal, and newborn health care is available,
accessible, and acceptable to all who need it (Table 2).
The themes point to the need to assess and address not
only the most proximal causes of maternal death, but
also the broad range of more distal systemic and social
determinants of maternal health and survival.
To support attaining the ambitious SDG MMR target
and the maternal health-related aims embedded in the
three pillars (“Survive Thrive, and Transform”) of the
UN Secretary General’s Global Strategy for Women’s,
Children’s and Adolescents’ Health (2016-2030) (Global
Strategy), it is essential for all countries to track and
monitor progress in the areas outlined in the key themes
[10]. In May 2015, the EPMM Working Group outlined
a two-phased plan to develop a comprehensive monitor-
ing framework to track national and global progress
towards improving maternal health and survival. The
first phase (Phase I) involved selecting measures to ad-
dress the most proximal causes of maternal mortality
while the second phase (Phase II) focused on identifying
indicators to address the distal causes (social, political,
and economic determinants) of maternal mortality.
Phase I, completed in October 2015, resulted in a set
of 12 core metrics for global monitoring and national
reporting by all countries, along with four priority areas
in which further work is required to develop other,
much needed indicators. This process was described by
Moran et al. (2016) [11]. The set of EPMM core metrics
from Phase I fed into the development of two key moni-
toring initiatives: the Indicator and Monitoring Frame-
work for the Global Strategy (published in February
2016), and the Countdown to 2030’s selection of cover-
age and demographic indicators for its country profiles
[12]. To date, global initiatives for tracking progress in
health have focused primarily on coverage and impact
measures for tracking key clinical interventions. For the
majority of the maternal health coverage and impact in-
dicators identified in Phase I, there is a history of stan-
dardized global and national-level monitoring. Thus, a
major achievement of that effort was to achieve consen-
sus on a priority set for global monitoring and national
reporting by all countries.
This paper, however, describes the process and results of
Phase II, which was completed in November 2016 and fo-
cused on identifying indicators that address the broad so-
cial, political, and economic determinants of maternal
health as outlined by the 11 key themes in the EPMM
Strategies. Because such distal determinants are risk factors
for poor maternal health outcomes as well as elements of
the enabling environment necessary for effective interven-
tions, addressing these distal determinants is a critical fac-
tor for successfully improving maternal health and survival
[13, 14]. Furthermore, recognition of the importance of
these more distal determinants of health continues to grow,
and experience demonstrates that when technical strategies
aiming to address maternal health risks do not include at-
tention to the broader supportive context, those strategies
are unlikely to succeed [3, 14] (Fig. 1).
Expanding the pursuit of optimal health from a simply
technical issue to a complex social phenomenon
reframes health improvement as a matter of social just-
ice, and indeed, in recent years, there has been an in-
crease in attention to maternal mortality reduction as a
human rights issue. Thus, the effort in Phase II to iden-
tify a set of supplementary indicators focused on the dis-
tal determinants of maternal health and survival serves
to support the Phase I work and to round out a compre-
hensive monitoring framework for EPMM based on a
human rights-based, social determinants approach to
maternal health.
Table 1 National and global maternal mortality rate targets
Global target for maternal mortality (SDG Target 3.1)
By 2030, reduce the global maternal mortality ratio to less than 70
deaths per 100,000 live births.
National targets for maternal mortality
By 2030, all countries should reduce their maternal mortality ratios by at
least two-thirds from 2010 baseline; countries with the highest maternal
mortality burdens will need a further reduction.
AND
By 2030, no country should have a maternal mortality ratio greater than
140 deaths per 100,000 live births, a number twice the global target.
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Methods
The Maternal Health Task Force (MHTF), the U.S.
Agency for International Development (USAID), and
WHO led the technical work to identify, evaluate, and
prioritize indicators on distal determinants of maternal
health and survival to reach consensus on a minimum
set for national and global level monitoring and report-
ing. The process is described in detail below.
A steering committee (composed of the authors of this
paper) was formed to plan and guide the indicator selec-
tion process. The steering committee was guided by the
following research question:
“Working within the specific context of maternal health,
and using the priority recommendations outlined in the
EPMM Strategies report, what are the 1-3 strongest
indicators available for each of the 11 EPMM key themes
from the EPMM Strategies report that can, together, help
track progress towards addressing the social, political, and
economic determinants of maternal health and survival?”
The steering committee conducted a review of selec-
tion criteria used to evaluate indicators in other measure
development efforts, comparing criteria from a number
of sources [12, 15–18]. The resulting set of selection cri-
teria were then used throughout the process (Table 3).
The Phase II indicators and stratifiers were identified
through a rigorous, iterative process that included mul-
tiple rounds of expert review and consultations con-
ducted over a period of eight months (Fig. 2). Guided by
the priority recommendations for each of the 11 key
themes in the EPMM Strategies report, the formative
Table 2 EPMM Key Themes
Guiding Principles 1. Empower women, girls, families and communities
2. Integrate maternal and newborn health, protect and support the mother-baby dyad
3. Prioritize country ownership, leadership, and supportive legal, regulatory and financial frameworks
4. Apply a human-rights framework to ensure that high-quality reproductive, maternal, and newborn health care is available,
accessible and acceptable to all who need it
Cross-cutting
Actions
5. Improve metrics, measurement systems, and data quality
6. Prioritize adequate resources and effective health care financing
Five Strategic
Objectives
7. Address inequities in access to and quality of sexual, reproductive, maternal and newborn healthcare
8. Ensure universal health coverage for comprehensive sexual, reproductive, maternal, and newborn healthcare
9. Address all causes of maternal mortality, reproductive and maternal morbidities and related disabilities
10. Strengthen health systems to respond to the needs and priorities of women and girls
11. Ensure accountability in order to improve quality of care and equity
Fig. 1 Structural Determinants of Health Inequities
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stage of the process, round 1, began with a mapping exer-
cise to identify potential indicators and, where applicable,
stratifiers for each theme. The priority recommendations
for each key theme from the EPMM Strategies report were
summarized and used to guide the search for relevant in-
dicators for that theme. Additional file 1 displays the pri-
ority recommendations, as well as the indicators mapped,
for each key theme.
Indicator mapping included a thorough review of the
peer-reviewed and gray literature to capture all indica-
tors currently in use, under development, and not cur-
rently in routine use. The search identified an average of
33 indicators for each theme. It should be noted that the
search for the theme focused on improving equity in ac-
cess to and quality of maternal and newborn health care
also included stratifiers, because an essential approach
to tracking equity is the disaggregation of data by spe-
cific factors (such as wealth, sex, or age) that place some
people at a social disadvantage. Such stratifiers allow
measurement of an indicator’s performance for subpop-
ulations relative to the total population that is captured
in the indicator’s denominator.
All indicators (and stratifiers) were independently
reviewed for quality by steering committee co-chairs
(AM and RJ), and indicators that clearly did not meet
the criteria were eliminated. The full steering committee
reviewed the remaining indicators, making further elimi-
nations. Differences of opinion were resolved through dis-
cussion. During round 1, an average of 11 potential
indicators per EPMM key theme (plus an additional seven
stratifiers for the equity-focused theme) was selected by
the steering committee for advancement to the second
round of expert and stakeholder review and consideration.
In the next two rounds, a modified Delphi method
was used to systematically evaluate and rank order po-
tential indicators, with the goal of identifying up to three
of the strongest available for monitoring each of the 11
key themes [19]. Round 2 of review included a series of
Table 3 Phase II Indicator Selection Criteria
Relevance • Indicator directly supports EPMM strategies for reducing preventable maternal mortality
• There is evidence that what the indicator measures is significantly associated with improved maternal health and
survival
Importance • Indicator resonates, and is valuable to decision makers and stakeholders
• Indicator “makes a difference” for improving maternal health and survival across countries and contexts
Interpretability &
Usefulness
• There is good/strong evidence to support the process, or the outcome
• Results point to areas for improvement and can advance strategic planning, policy or programming at different levels of
the system
Validity • Indicator measures what it is supposed to measure
• Indicator has been field-tested and used
• Indicator makes sense logically and scientifically
Feasibility & Data
Availability
• Based on the best available data of acceptable quality
• Data can be obtained with reasonable and affordable efforts in timely manner
• Data does not overly increase reporting burden on countries
Harmonization • Indicator strengthens or compliments existing efforts
• Indicator is recommended and being used by leading experts and organizations
• Indicator lacks redundancy and does not measure something already captured under other indicators
Fig. 2 Phase II Process to Develop a Monitoring Framework for EPMM
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11 webinars and 11 quantitative surveys (one webinar
and one follow-up survey per key theme). Each theme’s
webinar was attended by a panel of experts who were se-
lected to reflect technical, policy, and in-country moni-
toring expertise in the relevant subject area. The
steering committee decided on an ideal panel size of 10-
15 individuals based on the literature regarding sug-
gested Delphi method group size [20, 21]. For each
webinar an average of 62 experts were invited, and an
average of 18 experts ultimately participated.
The webinars were facilitated by a steering committee
co-chair (RJ) and panelists debated the merits of each
potential indicator against the selection criteria to agree
on the three strongest indicators for that theme. Follow-
ing each webinar, a quantitative survey was sent to the
full invitation list, including those who were unable to
join the webinar. In the survey, participants were asked
to score each indicator for quality using the predeter-
mined selection criteria and to rank up to three indica-
tors as the strongest for monitoring progress towards
the specific theme. For all 11 themes, the results of the
individual quantitative surveys confirmed the consensus
reached during the webinar discussion. In round 2, a
total of 118 indicators were evaluated, 50 indicators were
eliminated, and 38 indicators were selected for potential
inclusion in the final set of EPMM Phase II indicators.
Round 3 of the modified Delphi method consisted of a
final, summary webinar and corresponding online quan-
titative survey. In this round, the indicators that were
ranked among the top three during each of the 11 the-
matic webinars were evaluated as a full set and further
prioritized. This summary webinar included a total of 18
experts who participated in past webinars as well as add-
itional key stakeholders. The panel reviewed and rank-
ordered the 38 indicators that emerged from round 2,
ultimately eliminating seven indicators during this round
and bringing the total number of indicators in the draft
set of EPMM Phase II core indicators to 31.
Shifting from a focus on elimination, the fourth and
fifth rounds aimed to confirm the consensus and recom-
mendations from the previous rounds. To validate the
importance of the proposed indicators among a broad
group of maternal health stakeholders, round 4 was a re-
quest for public comment. This call for public comments
was posted online on the Maternal Health Task Force
website (MHTF.org) for a period of two weeks, and was
disseminated by email to multiple networks. The request
included an online survey in which participants were
asked to confirm, on a 4-point scale (“extremely import-
ant,” “moderately important,” “not at all important,” “don’t
know/no opinion”), the importance of each of the indica-
tors in the draft set of Phase II core indicators. Public
comment participants were also given the opportunity to
submit additional indicators for consideration, provided
that the indicator they submitted was not one that had
been evaluated and eliminated during previous rounds,
and that the submission included full information and
meta-data for that indicator. Nine additional indicators
were submitted via the request for public comment; after
review by the steering committee, three of those indicators
were eliminated due to incomplete information or dupli-
cation with indicators already included in the draft set.
The fifth and final round in this indicator development
process was an in-person, expert meeting to review and
confirm consensus on the draft set of indicators. The
meeting, hosted by the Maternal Health Task Force, in-
cluded 48 participants, representing country, technical,
and policy-making perspectives; many of the attendees
were also involved with the prior rounds of review. Prior
to the consultation, duplicates were removed from the
draft indicator set, minor modifications were highlighted,
and a set of outstanding questions for resolution by con-
sensus was drafted.
Ultimately, 150 experts from more than 78 organiza-
tions participated in this second phase of the process to
develop a comprehensive monitoring framework for
EPMM (Additional file 2). Guided by the 11 key themes
outlined in the EPMM Strategies report, experts consid-
ered a total of 118 indicators related to the social, polit-
ical, and economic determinants of maternal health and
survival.
Results
At the end of this process, consensus was obtained on
27 indicators and a set of six stratifiers. The stratifiers
were selected to enable the tracking of equity and trans-
parency. After removing duplicates, a total of 25 indica-
tors and six stratifiers comprise the final set of core
indicators for Phase II (Table 4). The definitions, recom-
mended disaggregators, and data sources for the final set
of indicators can be found in the indicator meta-data
(Additional file 3). Unlike Phase I of the process to de-
velop a monitoring framework for ending preventable
maternal mortality, which included input from 45 ex-
perts and resulted in 12 core indicators, the Phase II
process was much larger in scope; it ultimately included
input from three times as many experts and resulted in
double the number of indicators.
The Phase II indicators are well harmonized with the
Indicator and Monitoring Framework for the Global
Strategy, SDGs 3 and 5, and Countdown to 2015. Of the
25 indicators, 5 overlap with the Global Strategy, 14
overlap with the SDGs, and 11 overlap with Countdown
to 2015. (Table 5) Such harmonization is key to advan-
cing EPMM’s objective of supporting achievement of the
SDGs and the Global Strategy and complementing other
global monitoring efforts.
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A small number of outstanding issues remained with
regard to specific indicators, and were resolved through
a facilitated, semi-structured debate among participants
at the final expert meeting. The issues that guided this
debate and their resolutions are listed below.
1. Throughout the webinars and surveys, participants
recommended “minor modifications” to some
indicators. However, some of these recommended
modifications had potentially significant
implications for definition, data collection and
measurement. The group discussed whether
modification of any kind should warrant removal to
the additional set of indicators for further
development. The group consensus was to keep
these indicators on the core list in their original
form (without modification) and to add the
indicators along with the recommended
modifications to a secondary list of additional
indicators for further development.
2. An indicator tracking the presence and reporting of
data as described by ICD-PM2 was aspirational,
with no previous publication or use [22]. The group
agreed that this indicator should be removed to the
list of additional indicators for further development.
3. Six new indicators that were submitted through the
request for public comment were considered. These
indicators did not go through the same rigorous
iterative process of expert evaluation according to
selection criteria and prioritization via the modified
Delphi method. The expert group discussed and
agreed on next steps for each indicator, eliminating
four due to duplication, incomplete information or
failure to meet selection criteria; advancing one to
the list of additional indicators for further
development; and adapting one to develop a
stratifier focused on transparency.
An important secondary outcome of this iterative
process was the identification and prioritization of the
list of additional indicators that all participants in this
process agreed are relevant, important, and useful for
tracking progress toward EPMM strategic priorities, but
that require further development and research before
they can be recommended for global monitoring and
Table 4 EPMM Phase II Core Indicators
Indicator
Presence of laws and regulations that guarantee women aged 15-49
access to sexual and reproductive health care, information, and
education
Gender Parity Index (GPI)
Whether or not legal frameworks are in place to promote,
enforce, and monitor equality and non-discrimination on the
basis of sex
Presence of protocols/policies on combined care of mother and baby,
immediate breastfeeding, and observations of care
Maternity protection in accordance with ILO Convention 183
International Code of Marketing of Breastmilk Substitutes
Costed implementation plan for maternal, newborn, and child health
Midwives are authorized to deliver basic emergency obstetric and
newborn care
Legal status of abortion
Proportion of women aged 15-49 who make their own informed
decisions regarding sexual relations, contraceptive use, and
reproductive health care
Geographic distribution of facilities that provide basic and
comprehensive emergency obstetric care (EmOC)
Presence of a national set of indicators with targets and annual
report to inform annual health sector reviews and other planning
cycles
Maternal death review coverage
Percentage of total health expenditure spent on reproductive,
maternal, newborn, and child health
Out-of-pocket expenditure as a percentage of total expenditure on
health
Annual reviews are conducted of health spending from all financial
sources, including spending on RMNCH, as part of broader health
sector reviews
Health worker density and distribution (per 1000 population)
Coverage of essential health services
If fees exist for health services in the public sector, are women of
reproductive age (15-49) exempt from user fees for [MH-related
health] services
Demand for family planning satisfied through modern methods of
contraception
Availability of functional emergency obstetric care (EmOC) facilities
Density of midwives, by district (by births)
Percentage of facilities that demonstrate readiness to deliver specific
services: family planning, antenatal care, basic emergency obstetric
care, and newborn care
Civil registration coverage of cause of death (percentage)
Presence of a national policy/strategy to ensure engagement of civil
society organization representatives in periodic review of national




Area of residence: urban/rural
Table 4 EPMM Phase II Core Indicators (Continued)
Area of residence: geographic region
Level of education: women’s education level
Age
Transparency Stratifier
Available in the public domain
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national reporting. A total of 30 indicators fell into
this category. This process and the indicators that
emerged from it will be described in a separate
publication.
Discussion
The process and outcomes described above are a timely
and important contribution to global maternal health mon-
itoring. They address the lack of measures for the social,
Table 5 EPMM Phase II Core Indicators Harmonized with Other Monitoring Efforts
Indicator SDGs GS CD
Presence of laws and regulations that guarantee women aged 15-49 access to sexual and reproductive health care, information,
and education
✓ ✓
Gender Parity Index (GPI) ✓
Whether or not legal frameworks are in place to promote, enforce, and monitor equality and non-discrimination on the basis of sex ✓ ✓
Presence of protocols/policies on combined care of mother and baby, immediate breastfeeding, and observations of care
Maternity protection in accordance with ILO Convention 183 ✓
International Code of Marketing of Breastmilk Substitutes ✓
Costed implementation plan for maternal, newborn, and child health ✓
Midwives are authorized to deliver basic emergency obstetric and newborn care ✓
Legal status of abortion ✓ ✓
Proportion of women aged 15-49 who make their own informed decisions regarding sexual relations, contraceptive use, and re-
productive health care
✓ ✓
Geographic distribution of facilities that provide basic and comprehensive emergency obstetric care (EmOC)
Presence of a national set of indicators with targets and annual report to inform annual health sector reviews and other planning cycles ✓
Maternal death review coverage ✓
Percentage of total health expenditure spent on reproductive, maternal, newborn, and child health ✓
Out-of-pocket expenditure as a percentage of total expenditure on health ✓ ✓
Annual reviews are conducted of health spending from all financial sources, including spending on RMNCH, as part of broader
health sector reviews
Health worker density and distribution (per 1000 population) ✓ ✓
Coverage of essential health services
If fees exist for health services in the public sector, are women of reproductive age (15-49) exempt from user fees for [MH-related
health] services
Demand for family planning satisfied through modern methods of contraception
Availability of functional emergency obstetric care (EmOC) facilities
Density of midwives, by district (by births)
Percentage of facilities that demonstrate readiness to deliver specific services: family planning, antenatal care, basic emergency
obstetric care, and newborn care
Civil registration coverage of cause of death (percentage) ✓
Presence of a national policy/strategy to ensure engagement of civil society organization representatives in periodic review of




Area of residence: urban/rural ✓
Area of residence: geographic region ✓
Level of education: women’s education level ✓
Age ✓
Stratifier: Transparency
Available in the public domain
SDGs Sustainable Development Goals
GS Global Strategy for Women’s, Children’s and Adolescents’ Health (2016-2030)
CD Countdown to 2015
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political, and economic determinants of maternal health
and survival, complement other maternal health monitor-
ing efforts at the policy, system, and facility level, and pro-
vide a framework to support countries as they endeavor to
achieve the maternal health target set by the SDGs.
Maternal health and survival are situated within the
broader context of a woman’s full life course, including
but not limited to adolescence and sexual and repro-
ductive health. This continuum cannot be addressed in
isolation from the social and political dynamics and
structural inequalities that influence the systems in
which women not only live, but also seek and receive
healthcare [23, 24]. The SDGs and the Global Strategy
place emphasis on poverty reduction, gender equality,
universal health coverage, and a human rights approach
to health, exemplified by attention to the fundamental hu-
man rights principles of equity and non-discrimination,
transparency, participation, and accountability. Neverthe-
less, several commentaries highlight the lack of sufficient
global-level work on the development of measures for the
more distal determinants of health as we enter the SDG
period [25, 26]. Indeed, most global and national monitor-
ing frameworks focus heavily on indicators that track
health status and service coverage. For example, the
WHO Global Reference List of 100 Core Health Indica-
tors largely lacks indicators to track distal determinants of
health outcomes beyond measures of health system sta-
tus—such as enabling laws and policies, and social deter-
minants like education, gender, and socio-economic
barriers that impact on health status [27].
We acknowledge the critical importance of ongoing
work to determine the best measures to drive facility, com-
munity, national, and regional progress. But it is clear that
coverage and quality of essential clinical interventions at
the bedside (e.g. immediate administration of uterotonics
after birth), and the attendant improvement in health out-
comes at the client level (e.g., effective prevention of post-
partum hemorrhage), are highly dependent on upstream
factors such as adequate health workforce (e.g. density of
midwives), enabling policies (e.g. midwives are authorized
to deliver basic emergency obstetrics and newborn care)
and facility readiness (e.g. a reliable supply chain for essen-
tial commodities). These factors, in turn, are affected by
structural social, political, and economic factors, such as
the status of women in societies, measurement capacity
and data quality for effective surveillance and response,
and adequate allocation of resources to maternal health.
The burden on individual providers of collecting data
has been well documented [28, 29], as has the lack of use
of data collected at such great cost [30–32], which breaks
the feedback mechanism whereby monitoring and review
can result in improved provision of interventions. Global
level indicators to address social determinants of health
may seem distal, too, from the day to day process of
managing clinical care. Because the indicators identified
here were designed to tackle the social and distal determi-
nants of care, and aim to address determinants of health
that lie upstream from the most immediate factors which
influence a woman’s health outcome, they may seem be-
yond the scope of influence of the individual provider even
though typically, that provider lives and acts in the same
environment and is affected by the same cultural norms.
The results of tracking progress on social determinants
may not appear, at first blush, as immediate as counting
the number of women treated for PPH, but over time, in-
creases in girls’ educational attainment may well prove
greatly significant in ending preventable deaths [33, 34].
It is clear that global policies and strategies must be
grounded in the realities and challenges of care in set-
tings where women are dying. Real change, however,
must be systemic and will only come when the concept
that no woman should die in pregnancy or childbirth is
engrained throughout every culture and society as a fun-
damental right and an indisputable truth. Therefore, the
tripartite components of accountability adopted by the
Independent Accountability Panel—monitor, review, and
act—must be applied at every level from critical distal
determinants of maternal health and survival to those at
the bedside level in order to ensure high-quality, high-
performing health systems that are able to ensure the
highest attainable level of health for all.
Underscoring the need for more work in this area, in
March 2017 WHO established a Global RMNCAH Pol-
icy Reference Group (PRG) charged with advising WHO
on which policies to monitor under the umbrella of the
Global Strategy. In this context, the work described
above to identify relevant, useful, valid and feasible ma-
ternal health-specific indicators for less-developed global
monitoring areas such as health financing, laws, and pol-
icies was especially timely and important.
There are a number of global efforts to improve mater-
nal and newborn health monitoring at the policy, system,
and facility levels and the process to develop the Phase II
core indicators complemented these efforts well. At the
policy and systems level, for example, representatives from
the High-Level Working Group on Health and Human
Rights, the Commission on Social Determinants of Health,
the Global Financing Facility, the Countdown to 2030
Working Group on Drivers, and the WHO Health Policy
Reference Group were all included in several rounds of
the Phase II process, participating in webinars, surveys,
and the expert meeting, consulting on relevant themes,
and receiving information on the process’s outcomes
through direct outreach. This helped to ensure that the
Phase II process was well-coordinated with the aforemen-
tioned groups’ efforts to implement the Office of the High
Commissioner of Human Rights (OHCHR)’s “Technical
guidance on the application of a human rights-based
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approach to the implementation of policies and pro-
grammes to reduce preventable maternal mortality” [35].
In addition, coordination with the WHO Quality of Care
Network, Every Newborn Action Plan (ENAP), Improving
Coverage Measurement, and the Countdown to 2030 en-
sured that the Phase II process also complemented efforts
aimed at driving improvements at the facility level [36].
The outcomes of the Phase II process also comple-
ment a number of other maternal and newborn moni-
toring efforts, not least of which are the SDGs and
Global Strategy. Upon completion, the set of EPMM
Phase II indicators was delivered to the Mother New-
born Information for Tracking Outcomes and Results
(MONITOR) expert review group3, which was recently
formed by the WHO and tasked with advising the WHO
on maternal and newborn health monitoring, mapping
the full complement of available metrics for maternal
newborn health monitoring, and providing technical
guidance for the incorporation of those indicators into
routine use at country level. The Phase II set of indica-
tors has also been used in the development of the
Countdown to 2030’s indicator lists. Future steps for the
Phase II set include targeted testing and validation of the
indicators developed during this process and support for
their incorporation into global and national monitoring
frameworks and data systems for routine use.
There are numerous risks to progress for maternal
health in the current geopolitical context. The global
framework put forward in the SDGs is much broader than
that of the MDGs, with many more goals and targets;
there is a risk that the unfinished maternal health agenda
could fall through the cracks in the face of many more
competing priorities. Furthermore, there is also a risk of
sliding backwards on women’s sexual and reproductive
health and rights, which would have significant repercus-
sions for maternal health and survival [37]. Now more
than ever, attention is needed to ensure that maternal
health and survival remain high on the global develop-
ment agenda and tools and resources are readily available
to ensure effective, strategic action to achieve the goal of
ending preventable maternal deaths within a generation.
Fortunately, though collecting the indicator data may be
challenging, the EPMM Phase II indicators have multiple
implications for practical application. It is hoped that they
will be useful for national planning, reporting, and moni-
toring, as well as cross-ministerial work, “health in all” pol-
icies, and other best practices regarding strategic planning
and decision-making. They can provide a concrete moni-
toring framework for priority recommendations aimed at
achieving strengthened health systems. These indicators
acknowledge that health service quality is shaped at all
levels of the health system. Especially for formidable and
complex goals such as ensuring universal health coverage
of comprehensive sexual, reproductive, maternal and
newborn care, it is hoped that the indicators we propose
can provide a means of implementation for achieving and
tracking progress toward their progressive realization.
To further foster action at all levels of the health sys-
tem, the indicators may also be applied in the context of
social accountability and advocacy, an approach sup-
ported by the recommendations of the International Ini-
tiative on Maternal Mortality and Human Rights, which
calls for a rights-based approach to maternal mortality
reduction [37, 38]. Finally, they are intended to be useful
for global monitoring and reporting and thus to support
achievement of the SDGs and accountability for the full
realization of all three pillars of the Global Strategy in
the specific context of maternal health and survival.
Keeping in mind that ending preventable maternal mor-
tality is a country-driven endeavor, stakeholder recommen-
dations on the uses and target audiences for the final set of
EPMM Phase II indicators were compiled. Participants in
the expert meeting in particular proposed several sugges-
tions to improve the presentation and user-friendliness of
Phase II core indicator list. Suggestions included:
1. A comprehensive list of EPMM indicators that
includes the indicators from both Phases I and II;
2. Lists that display the indicators by harmonization
with other monitoring frameworks, key theme, and
maternal health topic area; and
3. Operational guidance to facilitate the prioritization,
selection, and use of EPMM indicators at the
country level based on context-specific needs
The first two suggestions have been addressed. The com-
prehensive list of Phase I and II indicators can be found in
Table 6. Lists displaying the Phase II indicators by key
theme, harmonization with other monitoring frameworks,
and maternal health topic area can be found in Additional
file 1, Table 5, and Additional file 4, respectively. Mecha-
nisms to address country requests for operational guidance
to facilitate context-specific use of the indicators are under
development by the EPMM Working Group.
This process included both strengths and limitations.
One strength of this project was the use of a rigorous, sys-
tematic, and iterative process based on sound method-
ology. Another strength was the broad participation from
maternal health stakeholders worldwide, which was
achieved via active outreach to numerous constituencies
and experts in sexual, reproductive maternal and newborn
health, human rights, health policy, workforce planning,
measure development, clinical quality improvement,
health economics and financing, epidemiology, demog-
raphy and health statistics and other relevant domains.
Participants were from government agencies and non-
governmental organizations, national Ministries of Health,
bilateral and donor organizations, academic and research
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Table 6 EPMM Phase I and Phase II Core Indicators
Phase I Indicators Phase II Indicators
Coverage
Four or more antenatal visits Proportion of women ages 15-49 who make their own informed decisions regarding sexual
relations, contraceptive use, and reproductive health care
Skilled attendant at birth Maternal death review coverage
Institutional delivery Coverage of essential health services
Maternal death registration Demand for family planning satisfied through modern methods of contraception
Early postnatal/postpartum care for woman and
baby (within 2 days of birth)
Civil registration coverage of cause of death (percentage)
Met need for family planning
Uterotonic immediately after birth
Caesarean rate
Health Systems Strengthening & Finance
Availability of functional emergency obstetric
care facilities
Availability of functional emergency obstetric care facilities
Geographic distribution of facilities that provide basic and comprehensive emergency obstetric
care
Health worker density and distribution (per 1000 population)
Density of midwives, by district (by births)
Percentage of facilities that demonstrate readiness to deliver specific services: family planning,
antenatal care, basic emergency obstetric care, and newborn care
Percentage of total health expenditure on reproductive, maternal, newborn, and child health
Out-of-pocket expenditure as a percentage of total expenditure on health
Impact
Maternal mortality ratio




Presence of laws and regulations that guarantee women ages 15-49 access to sexual and reproductive
health care, information, and education
Gender Parity Index
Whether or not legal frameworks are in place to promote, enforce, and monitor equality and
non-discrimination on the basis of sex
Presence of protocols/policies on the combined care of mother and baby, immediate
breastfeeding, and observations of care
Maternity protection in accordance with ILO Convention 183
International Code of Marketing of Breastmilk Substitutes
Costed implementation plan for maternal, newborn, and child health
Midwives authorized to deliver basic emergency obstetric and newborn care
Legal status of abortion
Presence of a national set of indicators with targets and annual report to inform annual health
sector reviews and other planning cycles
If fees exist for health services in the public sector, women of reproductive age (15-49) are
exempt from user fees for maternal health-related health services
Annual reviews are conducted of health spending from all financial sources, including spending
on RMNCH, as part of broader health sector reviews
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institutions, policy think tanks, clinical care facilities and
program administration, among others.
There were also some limitations to this process. First,
the number of participants at each stage was limited des-
pite concerted efforts to be inclusive and representative.
Second, many indicators recommended for inclusion in
the final set have not yet been validated and tested at the
national level. As noted above, however, work is currently
being planned to test and validate these indicators. Finally,
many indicators considered by the experts involved in this
process were deemed important, relevant, and useful for
tracking progress in key thematic areas but still in need
further development before being recommended for mon-
itoring at global and national levels. Those indicators
could not be included in the core set of indicators. Never-
theless, this set of additional indicators for further devel-
opment represents an important agenda for future
research in the area of measure development for maternal
newborn health monitoring, and provides a strong basis
and rationale for the need for further work in this area.
Finally, a point of frequent discussion among partici-
pants in this process was that the mere presence of a pol-
icy does not indicate its effective implementation or
impact. The policy indicators recommended here provide
a point of entry for monitoring in these areas. Monitoring
the presence of policies that aim to improve maternal
health and survival establishes a basis for advocacy and
holds policy makers to account for the effective imple-
mentation of said policies, as well as, when necessary, ef-
fective redress in the event of non-compliance. Consistent
with the human rights concept of progressive realization,
therefore, we recognize that indicators that capture the ex-
istence of policies addressing the social determinants of
maternal health and survival, while necessary, may not be
sufficient and look forward to further progress toward en-
suring measures of effective implementation, and eventu-
ally, measures that track the impact of such policies [26].
We look forward to the work of the recently established
WHO Policy Reference Group in this area. At the same
time, we hope that providing even an imperfect entry
point for monitoring critical distal determinants of mater-
nal health and survival will represent a useful contribution
toward creating the enabling environment for functional
health systems that are able to deliver high-quality care to
all women and end preventable maternal deaths. Greater
attention is being given to the roles that poorly function-
ing health systems and unaddressed upstream factors play
in creating barriers to the provision of critical lifesaving
interventions by frontline workers [3]. The role of the
health system has also been described and specifically
called out in the process of refining the definition of
skilled attendance at birth [39]. The resulting moral dis-
tress and burnout they face [40, 41] thus highlights yet an-
other way in which these distal determinants significantly
influence provision and experiences of care at the facility
level where maternal and perinatal deaths and disabilities
occur and the rights of women are violated.
Conclusion
Ending preventable maternal mortality and correcting un-
acceptable levels of disparity are essential to achieving
SDG 3, which focuses on global health for all. Considering
the critical role women play in families, economies, and so-
cieties, and in the development of future generations and
communities, their needs cannot be ignored. Now is a time
of both opportunity and threat for the global maternal
health agenda. There is a very real risk that the focus
needed to improve maternal health and survival will be lost
in the broad new SDG framework and the unfinished
agenda for maternal health will not be completed. At the
same time, there is research suggesting that we could end
preventable maternal deaths within a generation and
achieve “a grand convergence” by eliminating wide dispar-
ities in current maternal mortality and reducing the highest
levels of maternal deaths worldwide to rates now observed
in the best-performing middle-income countries [42].
In concluding our paper on Phase I of the process to
develop a comprehensive monitoring framework for
Table 6 EPMM Phase I and Phase II Core Indicators (Continued)
Phase I Indicators Phase II Indicators
Presence of a national policy/strategy to ensure engagement of civil society organization
representatives in periodic review of national programs for maternal, newborn, child, and
adolescent health
Equity and Transparency (Stratifiers)
Wealth
Area of residence: urban/rural
Area of residence: geographic region
Level of education: women’s education level
Age
Available in the public domain
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EPMM we cited the adage, “What gets measured gets
done” [11]. The broad focus of the EPMM Strategies ad-
dresses not only the essential clinical interventions
needed to save lives but also the equally important polit-
ical, social, economic and health system determinants of
maternal health and survival. These factors are essential
to creating the enabling environment and high-
performing health systems needed to ensure high-
quality clinical care at the point of service for every
woman, her fetus and newborn. Without a monitoring
framework and robust measures for tracking progress
in these more distal areas for improvement, their im-
portance remains largely rhetorical. This paper comple-
ments Phase I by rounding out the set of core maternal
health indicators focused on coverage and impact of
key interventions closely linked to the more proximal
causes of death with a set of maternal health policy and
health system indicators focused on the more distal, yet
still critical social, political, and economic determinants
of maternal health and survival highlighted in the
EPMM Strategies.
The indicators identified through the process de-
scribed above provide a concrete tool to support the
implementation of monitoring progress towards each
of the 11 key themes outlined EPMM Strategies re-
port. It is hoped that national and global decision
makers and program planners will find them to be
useful tools for accelerating progress toward eliminat-
ing the disparities driven by social determinants,
structural inequalities, and system deficiencies that
contribute to preventable maternal deaths around the
world. Together, the EPMM Strategies and its accom-
panying monitoring framework—developed through
the consultative process described above—support
achievement of the SDGs and Global Strategy within
the specific domain of maternal health.
Endnotes
1A coalition made up of the World Health Organization
and partner organizations which include the FCI Program
of Management Sciences for Health, Jhpiego, Mater-
nal and Child Survival Program, Maternal Health Task
Force, UNFPA, UNICEF, USAID, and White Ribbon
Alliance.
2WHO describes ICD-PM as “the WHO application
of ICD-10 deaths during the perinatal period… it is
intended to facilitate the consistent collection, ana-
lysis, and interpretation of information on perinatal
deaths.”
3The Terms of Reference for the newly formed MONI-
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